Yanhao Jiang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Klebsiella Pneumoniae

Natural Killer Cells

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Zhiren Wang, Wenpan Li, Yanhao Jiang, Jonghan Park, Karina Marie Gonzalez, Xiangmeng Wu, Qing-Yu Zhang, Jianqin Lu
Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery. Nature communications 15 (1) (2024)
Zhiren Wang, Wenpan Li, Yanhao Jiang, Jonghan Park, Karina Marie Gonzalez, Xiangmeng Wu, Qing-Yu Zhang, Jianqin Lu
Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery. Nature communications 15 (1) (2024)
Zhiren Wang, Wenpan Li, Yanhao Jiang, Jonghan Park, Karina Marie Gonzalez, Xiangmeng Wu, Qing-Yu Zhang, Jianqin Lu
Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery. Nature communications 15 (1) (2024)
Zhiren Wang, Wenpan Li, Yanhao Jiang, Jonghan Park, Karina Marie Gonzalez, Xiangmeng Wu, Qing-Yu Zhang, Jianqin Lu
Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery. Nature communications 15 (1) (2024)
Zhiren Wang, Wenpan Li, Yanhao Jiang, Jonghan Park, Karina Marie Gonzalez, Xiangmeng Wu, Qing-Yu Zhang, Jianqin Lu
Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery. Nature communications 15 (1) (2024)
Yanhao Jiang, Wenpan Li, Zhiren Wang, Jianqin Lu
Lipid-Based Nanotechnology: Liposome. Pharmaceutics 16 (1) (2023)
Yanhao Jiang, Wenpan Li, Zhiren Wang, Jianqin Lu
Lipid-Based Nanotechnology: Liposome. Pharmaceutics 16 (1) (2023)
Yanhao Jiang, Wenpan Li, Zhiren Wang, Jianqin Lu
Lipid-Based Nanotechnology: Liposome. Pharmaceutics 16 (1) (2023)
Zhiren Wang, Wenpan Li, Yanhao Jiang, Tuyen Ba Tran, Leyla Estrella Cordova, Jinha Chung, Minhyeok Kim, Georg T Wondrak, Jennifer Erdrich, Jianqin Lu
Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy. Nature communications 14 (1) (2023)
Yanhao Jiang, Wenpan Li, Zhiren Wang, Jianqin Lu
Lipid-Based Nanotechnology: Liposome. Pharmaceutics 16 (1) (2023)